Codexis

Codexis Revenue

The The revenue of Codexis (CDXS) as of Oct 17, 2026 is 70.39 M USD. In the previous year, The revenue was 59.35 M USD — a change of 18.61% (higher).

Revenue

70.39 MUSD

YoY

18.61%

Last updated:

In 2025, Codexis's sales reached 70.39 M USD, a 18.61% difference from the 59.35 M USD sales recorded in the previous year.

Over the last 19 years Codexis grew revenue by 9.7% annually, reaching 70.39 M USD.

The Codexis Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
Date
Revenue
Jan 1, 2023
70.14 M USD
Jan 1, 2024
59.35 M USD
Jan 1, 2025
70.39 M USD
Jan 1, 2026 (e)
73.89 M USD
Jan 1, 2027 (e)
87.69 M USD
Jan 1, 2028 (e)
111.15 M USD
Jan 1, 2029 (e)
139.17 M USD
Jan 1, 2030 (e)
166.07 M USD
The Codexis Revenue history
YEARRevenueYoY
est166.07 MUSD+19.33%
est139.17 MUSD+25.21%
est111.15 MUSD+26.75%
est87.69 MUSD+18.68%
est73.89 MUSD+4.97%
70.39 MUSD+18.61%
59.35 MUSD-15.39%
70.14 MUSD-49.39%
138.59 MUSD+32.30%
104.75 MUSD+51.69%
69.06 MUSD+0.87%
68.46 MUSD+12.98%
60.59 MUSD+21.13%
50.02 MUSD+2.43%
48.84 MUSD+16.82%
41.80 MUSD+18.40%
35.31 MUSD+10.60%
31.92 MUSD-63.85%
88.30 MUSD-28.71%
123.87 MUSD+15.65%
107.10 MUSD+29.18%
82.91 MUSD+64.25%
50.48 MUSD+99.26%
25.33 MUSD+108.90%
12.13 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Codexis Revenue

Codexis Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
70.14 M USD
-68.07 M USD
-76.24 M USD
Jan 1, 2024
59.35 M USD
-58.52 M USD
-65.28 M USD
Jan 1, 2025
70.39 M USD
-41.74 M USD
-43.97 M USD
Jan 1, 2026 (e)
73.89 M USD
-31.58 M USD
-33.93 M USD
Jan 1, 2027 (e)
87.69 M USD
-19.61 M USD
-24.99 M USD
Jan 1, 2028 (e)
111.15 M USD
-3.62 M USD
-10.24 M USD
Jan 1, 2029 (e)
139.17 M USD
9.33 M USD
6.32 M USD
Jan 1, 2030 (e)
166.07 M USD
22.56 M USD
17.16 M USD

Codexis Margins

Codexis stock margins

The Codexis margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Codexis. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Codexis.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2023
81.74 %
-97.04 %
-108.69 %
Jan 1, 2024
72.55 %
-98.61 %
-109.99 %
Jan 1, 2025
86.73 %
-59.30 %
-62.47 %
Jan 1, 2026 (e)
86.73 %
-42.74 %
-45.93 %
Jan 1, 2027 (e)
86.73 %
-22.37 %
-28.50 %
Jan 1, 2028 (e)
86.73 %
-3.26 %
-9.21 %
Jan 1, 2029 (e)
86.73 %
6.70 %
4.54 %
Jan 1, 2030 (e)
86.73 %
13.59 %
10.33 %

Codexis Stock analysis

What does Codexis do? Codexis Inc. is an American biotechnology company that specializes in developing innovative biological solutions for a variety of industries. The company was founded in 2002 and is headquartered in Redwood City, California. Business Model: Codexis is service-oriented and provides customized enzyme solutions for companies looking to improve their products through sustainable processes. The company has developed a unique platform called Rational Protein Engineering, which allows for the development of specific enzymes for various industries. Customers benefit from enzyme optimization expertise and know-how. Divisions: Codexis operates in the fields of life sciences, materials science, agrochemicals, and biofuels. 1. Life Sciences: Codexis specializes in the production of enzymes and biocatalysts for the pharmaceutical industry in the life sciences division. The goal is to provide a faster and more efficient manufacturing process for pharmaceutical active ingredients. The company has successfully developed active ingredients for antibodies, lipids, uric acid, and antivirals. 2. Materials Science: In the materials science division, Codexis specializes in the production of enzymes for materials such as dyes, polymers, and cosmetic products. Codexis ensures that these products are efficiently manufactured without the use of environmentally harmful chemicals. 3. Agrochemicals: Codexis offers customized enzyme solutions to agrochemical manufacturers that reduce the use of chemicals and benefit the environment. These enzymes help in the production of pesticides and other agrochemicals. 4. Biofuels: In the biofuels division, Codexis specializes in the production of enzymes for processing corn, harvested plants, or waste products. These enzymes help enable cost-effective biofuel production. Products: Codexis has developed a wide range of products tailored to the needs of various industries. Some of the products recently introduced to the market by Codexis include: 1. CodeEvolver: CodeEvolver is a platform that allows biotechnology companies to quickly create customized enzyme solutions for their specific needs. The process is fully automated and results in a significant reduction in development time and costs. 2. Codex® screening panels: Codexis offers various screening panels that allow customers to quickly and efficiently select the enzymes best suited for their purposes. The panels are suitable for industries including pharmaceuticals, chemicals, and plant protection. 3. Codex® enzymes: Codexis offers a wide range of enzymes specifically designed for different industry needs. This includes enzymes for the production of biofuels, pesticides, cosmetic products, and pharmaceuticals. Overall, Codexis Inc. has demonstrated its ability to deepen the understanding of biocatalysts and introduce innovative biological processes in a variety of industries through its unique Rational Protein Engineering platform. Codexis is one of the most popular companies on Eulerpool.

Revenue Details

Understanding Codexis's Sales Figures

The sales figures of Codexis originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Codexis’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Codexis's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Codexis’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Codexis stock

The revenue of Codexis is 70.39 M USD in 2025.

The revenue of Codexis changed from 59.35 M USD to 70.39 M USD, representing a 18.61% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The revenue Codexis since 2006 – with annual values, charts, and detailed analysis.

Revenue is the total value of all goods sold in a period. It is calculated by multiplying the quantity of each product sold by its selling price. Revenue does not include any costs (material costs, personnel costs, etc.), whereas net proceeds only deduct revenue reductions associated with the sale (discounts, etc.).

The revenue's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The revenue's Codexis historically and in real time.

The revenue in assessing a stock

Revenue is an important financial measure used in the valuation of stocks. It is a measure of a company's economic activity and can serve as an indicator of the company's success. Revenue is considered one of the most important factors in stock valuation. In addition, revenue can also be used to calculate other financial measures such as earnings per share and price-earnings ratio.

History and utilization of revenue

Revenue has long been considered one of the most important financial indicators. It was used in the 19th century as one of the first financial indicators to measure a company's economic activity. Since then, revenue has been regularly used to evaluate companies.

Revenue is usually calculated as a percentage of the company's equity. It can also be used to determine the overall profitability of a company. There are many different types of revenue that can be used to measure a company's economic activity, such as gross revenue, net revenue, and revenue from international business.

The revenue can also be used to evaluate stocks. For example, the revenue of a company can be used to evaluate the success of the company. If a company has high revenue, it means that it is a profitable company because it has high demand for its products or services.

Calculation and Application of Revenue

In order to calculate a company's revenue, the company's income must be deducted from its expenses. The income can come from various sources, such as sales, licensing fees, services, etc. The expenses can include costs for production, procurement, inventory, sales, and administration.

The revenue can then be used to calculate various financial ratios. For example, the revenue can be used to calculate the price-earnings ratio (P/E ratio) of a company. This is a measure of a company's profitability, calculated by taking the ratio of the stock price to earnings per share.

Revenue can also be used to calculate earnings per share (EPS) of a company. This is a measure of a company's profit per share. EPS is calculated by dividing earnings by the number of shares issued.

Use of revenue by investors

Investors use revenue to evaluate stocks, as revenue is an indicator of a company's success. For example, an investor can compare a company's revenue to see how successful it is. An investor can also use a company's revenue to calculate its price-to-earnings ratio and earnings per share.

An example: An investor looks at a company that has a revenue of 25 million euros. He compares this revenue to that of the competitor, which has a revenue of 35 million euros. The investor can then see that the company with 25 million euros in revenue is less successful than the company with 35 million euros in revenue.

Advantages and Disadvantages of Revenue.

Revenue is a very useful tool for valuing stocks as it measures a company's economic activity. Revenue can also be used to calculate other financial ratios such as the price-earnings ratio and earnings per share.

However, one disadvantage is that revenue alone is not a meaningful indicator of a company's success. It is important to consider revenue in comparison to other financial metrics such as earnings per share and price-to-earnings ratio to get a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Codexis

All Key Metrics — Codexis